|
FOR: CARDIOCOMM SOLUTIONS, INC.
TSX VENTURE SYMBOL: EKG
Arrhythmia Surveillance
Utilized HeartCheck™ Device and SMART
Monitoring ECG Service Technologies
TORONTO, ONTARIO - CardioComm
Solutions, Inc. (TSX VENTURE:EKG)
("CardioComm Solutions" or the "Company")today
announced that it is working within a pilot that
uses HeartCheck™ ECG testing technology to
support arrhythmia screening and surveillance
with long-term care facilities. The pilot was
coordinated by Toronto-based In Initiative Inc.
and conducted with Responsive Management Inc.
("RMI"), an organization that owns and operates
nine long-term care homes and three retirement
residences in Ontario. The program will utilize
the HeartCheck™ ECG monitor and SMART Monitoring
ECG service technologies enabled through GEMS™
Home and focuses on the early detection of
atrial fibrillation ("AF"). The arrhythmia
surveillance program system was implemented as
part of a larger project funded by an education
grant provided by Boehringer Ingleheim (Canada)
Inc.
Residents of long-term care facilities are
at a higher risk for developing arrhythmias due
to their age or co-morbid conditions, or both.
Central to a program of arrhythmia surveillance
is the ability to easily and accurately capture
an ECG at the time a resident is exhibiting
symptoms. The resident's provider performs the
ECG recording using the HeartCheck™ ECG monitor
and then uploads the recording to the CardioComm
Solutions SMART Monitoring ECG service via
GEMS™ Home from a workstation at a designated
nursing station. Through the cloud-based SMART
Monitoring service, ECGs are interpreted by
Canadian physicians who are specifically
assigned to the RMI ECG records. Once
interpreted, ECG reports are then automatically
returned to the long-term care facility, using
HIPPA compliant data encryption technologies,
where the reports are reviewed by the physician
in charge through GEMS™ Home.
The goal of the
arrhythmia surveillance program is to assist
long-term care facilities with the early
detection of life threatening arrhythmias,
especially AF, and improve the care of the
residents. "AF related strokes in the elderly
are more disabling and more likely to be fatal.
At RMI, we are focused on introducing best
practice initiatives that improve the well-being
of our residents through a resident-centric
approach in everything we do," said Derrick
Hoare, Vice President Operations, Responsive
Management Inc. "We did not realize how much of
a problem AF is in our homes but now have a
framework to detect and address the issue. Using
a multi-disciplinary team of professionals and
the CardioComm Solutions technologies, a care
protocol has been implemented that addresses
early AF detection and initiation of optimal
therapy."
"We are excited to be part of this
initiative designed to develop a standardized
approach to prevent strokes in our residents.
The pilot project addresses an unmet need and we
expect that initial results will be presented
soon," said Susan Veenstra, Director of Nursing
and Wellness at Responsive Management Inc.
"RMI has shown leadership in the adoption of a
new technology within the daily medical
management of their residents. The RMI ECG
surveillance program incorporates best practice
guidelines to support ongoing ECG testing for
all residents and the training of staff to
recognize and respond appropriately to signs of
AF with the goal of preventing the occurrence of
strokes through early AF detection. The program
will reduce unnecessary and costly transfers to
the ER which are stressful to the resident and
may result in the arrhythmia not being found
given the episodic nature of AF," said Etienne
Grima, CEO of CardioComm Solutions. "We have
been piloting the HeartCheck™ devices since
August 2013 and are now fully implemented in
three of the RMI locations. A major advance was
the GEMS™ Home 1.2 release that allows the
HeartCheck™ ECG handheld monitor to interface
with the SMART Monitoring ECG service. We look
forward to the successful roll out of the
solution in all of the RMI Ontario locations
over the next few months and to contributing to
their mission of maintaining the best level of
care possible for their residents."
"There are more than 630 long-term care
facilities in Ontario alone, according to the
Ministry of Health and Long-Term Care (MOHLTC),"
noted Simi Grosman, a member of the Company's
Board of Directors. "Replicating these numbers
across the country speaks to a significant and
rapidly expanding market for CardioComm
Solutions' HeartCheck™ ECG monitor and SMART
Monitoring ECG service technologies. The
potential impact that we can make on the early
detection of arrhythmias and AF cannot be
overstated."
More information regarding the HeartCheck™
products and SMART Monitoring solutions is
available at the Company's web site
www.theheartcheck.com.
download pdf 
CardioComm Solutions' patented and proprietary
technology is used in products for recording,
viewing, analyzing and storing
electrocardiograms (ECGs) for diagnosis and
management of cardiac patients. Products
are sold worldwide through a combination of an
external distribution network and a North
American-based sales team. The Company has
earned the ISO 13485 certification, is HPB
approved, HIPAA compliant, and has received FDA
market clearance for its software devices.
CardioComm Solutions is headquartered in
Toronto, Canada, with offices in Victoria,
B.C.
FOR FURTHER
INFORMATION PLEASE CONTACT:
Etienne Grima, Chief Executive Officer
1-877-977-9425
investorrelations@cardiocommsolutions.com
www.cardiocommsolutions.com
Forward-looking
statements
This release may contain certain forward-looking
statements and forward looking information with
respect to the financial condition, results of
operations and business of CardioComm Solutions
and certain of the plans and objectives of
CardioComm Solutions with respect to these
items. Such statements and information reflect
management's current beliefs and are based on
information currently available to management.
By their nature, forward-looking statements and
forward-looking information involve risk and
uncertainty because they relate to events and
depend on circumstances that will occur in the
future and there are many factors that could
cause actual results and developments to differ
materially from those expressed or implied by
these forward-looking statements and
forward-looking information.
In evaluating these statements, readers should:
specifically consider risks discussed under the
heading "Risk Factors" in the Company's Annual
Information Form, available at www.sedar.com;
not to place undue reliance on forward-looking
statements and forward-looking information; be
aware. the Company does not assume any
obligation to update the forward-looking
statements and forward-looking information
contained in this Annual Information Form other
than as required by applicable laws (including
without limitation Section 5.8(2) of National
Instrument 51-102 (Continuous Disclosure
Obligations).
Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in
policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of
this release.
|
